Previous Close | 17.31 |
Open | 17.67 |
Bid | 16.90 x 1000 |
Ask | 17.45 x 1400 |
Day's Range | 16.87 - 17.67 |
52 Week Range | 1.77 - 26.86 |
Volume | |
Avg. Volume | 44,803 |
Market Cap | 691.395M |
Beta (5Y Monthly) | -3.49 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for PHVS
While August brought with it a pullback following the market’s strong performance so far this year, the past few sessions have seen momentum build again. The good news, according to Andrew Slimmon, managing director and senior portfolio manager at Morgan Stanley Investment Management, is that the market’s advance is set to continue. Boosted by the Q3 earnings season, Slimmon sees the S&P 500 nearing the 5,000 mark by the end of the year, which would not only represent an 11% increase from curren
We can readily understand why investors are attracted to unprofitable companies. Indeed, Pharvaris ( NASDAQ:PHVS...
Redfin upgraded, CSSE downgraded: Wall Street's top analyst calls